Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPIVACAINE Cause Multiple sclerosis relapse? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Multiple sclerosis relapse have been filed in association with BUPIVACAINE (Bupivacaine Hydrochloride). This represents 0.1% of all adverse event reports for BUPIVACAINE.

10
Reports of Multiple sclerosis relapse with BUPIVACAINE
0.1%
of all BUPIVACAINE reports
1
Deaths
6
Hospitalizations

How Dangerous Is Multiple sclerosis relapse From BUPIVACAINE?

Of the 10 reports, 1 (10.0%) resulted in death, 6 (60.0%) required hospitalization.

Is Multiple sclerosis relapse Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPIVACAINE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does BUPIVACAINE Cause?

Drug ineffective (3,068) Off label use (912) Pain (746) Anaesthetic complication (585) Maternal exposure during pregnancy (491) Hypotension (460) Hypoaesthesia (455) Exposure during pregnancy (391) Nausea (328) Drug withdrawal syndrome (280)

What Other Drugs Cause Multiple sclerosis relapse?

DIMETHYL (6,852) FINGOLIMOD (6,728) NATALIZUMAB (6,478) INTERFERON BETA-1A (5,931) TERIFLUNOMIDE (4,745) GLATIRAMER (3,695) DALFAMPRIDINE (3,322) OCRELIZUMAB (2,326) OFATUMUMAB (1,525) INTERFERON BETA-1B (1,229)

Which BUPIVACAINE Alternatives Have Lower Multiple sclerosis relapse Risk?

BUPIVACAINE vs BUPIVACAINE\BUPIVACAINE ANHYDROUS BUPIVACAINE vs BUPIVACAINE\EPINEPHRINE BUPIVACAINE vs BUPIVACAINE\MELOXICAM BUPIVACAINE vs BUPRENORPHINE BUPIVACAINE vs BUPRENORPHINE\NALOXONE

Related Pages

BUPIVACAINE Full Profile All Multiple sclerosis relapse Reports All Drugs Causing Multiple sclerosis relapse BUPIVACAINE Demographics